The Rapid Acceleration of Diagnostics (RADx) initiative from the National Institutes of Health was launched in April 2020 in response to the COVID-19 pandemic to speed the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improve clinical laboratory tests, that can directly detect the virus.